Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)
CAPS Rating:
A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.
A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.
Recs
This one has better potential of going up and less risk of going down in long term from this point on. Co will be bought out at a price more than what it is trading at now.